Tirzepatide is a first-in-class medication that acts as a dual receptor agonist, mimicking two natural gut hormones:
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By activating both receptors, it provides more significant weight loss and blood sugar control than medications that target GLP-1 alone.
For research use only, not to be used in clinical trials involving humans. Documentation is for information only.
Note:
With this option, we will mix it for you with bacteriostatic water and put it into a disposable pen (no vial received). The pen offers easy and accurate dosing for your research purposes, adjustable from 1 to 60 iu’s. It comes complete with enough alcohol swabs and needles to complete your research, all contained in a case.
If you already have a reusable pen you can also buy this peptide premixed in a cartridge only (see alternate product).